Cancers originating in the esophagus, gastroesophageal junctions, and stomach constitute a major health problem worldwide. In the United States, 37,600 new diagnoses of and 25,150 deaths from upper gastrointestinal cancers were estimated in 2009. 1 A dramatic shift in the location of upper gastrointestinal tumors has occurred in the United States, 2 and changes in histology and location of them were observed in some parts of Europe. 3,4 In countries in the Western Hemisphere, the most common sites of gastric cancer are the proximal lesser curvature, cardia, and gastro-The NCCN

Composite films containing various percentages of banana starch and low‐density polyethylene (LDPE) were prepared. The effects of the compatibilizer, banana starch content, and photosensitizer content on the thermal and tensile properties of these films were investigated. The banana starch content was varied from 5 to 20 wt % of LDPE, whereas benzophenone was added as a photosensitizer in three different amounts (0.25, 0.5, and 1 wt %) based on LDPE. In these films PE‐graft‐maleic anhydride (PE‐g‐MA) was used as a compatibilizer at 10 wt % banana starch. It was found that the thermal stability of the composite films remained unchanged with respect to the amount of banana starch and benzophenone content. The addition of banana starch had no effect on the melting temperature and degree of crystallinity of the films. Similarly, PE‐g‐MA had no effect on the melting temperature but decreased the degree of crystallinity of the LDPE phase. Benzophenone caused an increase in the melting temperature but decreased the degree of crystallinity of LDPE in the films. Increasing the amount of banana starch decreased the tensile properties of the composite films. The addition of PE‐g‐MA as a compatibilizer increased the tensile properties compared with the uncompatibilized films. However, benzophenone had no effect on the tensile properties of the blend films. © 2006 Wiley Periodicals, Inc. J Appl Polym Sci 100: 2717–2724, 2006

No abstract

Outcomes in patients with gastric cancer in the United States remain disappointing, with a five-year overall survival rate of approximately 23%. Given high rates of local-regional control following surgery, a strong rationale exists for the use of adjuvant radiation therapy. Randomized trials have shown superior local control with adjuvant radiotherapy and improved overall survival with adjuvant chemoradiation. The benefit of adjuvant chemoradiation in patients who have undergone D2 lymph node dissection by an experienced surgeon is not known, and the benefit of adjuvant radiation therapy in addition to adjuvant chemotherapy continues to be defined. In unresectable disease, chemoradiation allows long-term survival in a small number of patients and provides effective palliation. Most trials show a benefit to combined modality therapy compared to chemotherapy or radiation therapy alone. The use of pre-operative, intra-operative, 3D conformal, and intensity modulated radiation therapy in gastric cancer is promising but requires further study. The current article reviews the role of radiation therapy in the treatment of resectable and unresectable gastric carcinoma, focusing on current recommendations in the United States.